Yang, Z. (2018). Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationYang, Z. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationYang, Z. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.